Skip to main content
HCPCS J3301 · Level II · Part B drug

J3301: triamcinolone acetonide (Kenalog-80, Kenalog-40), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J3301

Billing unit
10 MG
Triamcinolone acet inj nos
ASP payment limit
$0.787
October 2026; -21.0% vs July 2026
Practitioner MUE
16
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
2
8 states

TL;DR

HCPCS J3301 is the Level II code for Injection, triamcinolone acetonide, not otherwise specified, 10 mg, billed per 10 MG. The Medicare Part B ASP payment limit for October 2026 is $0.787 per billing unit, down 21.0% from July 2026. The practitioner MUE allows up to 16 units per date of service (MAI 3), so a full 16-unit day is $12.59 at the current limit. Under OPPS it carries status indicator N. The 10 mg billing unit means doses are reported in multiples of ten milligrams, with any remainder rounded per contractor policy; mismatched units against the NDC quantity trigger MUE and NDC-unit edits. Other HCPCS codes whose descriptor names triamcinolone acetonide: J3300 (Triesence from Harrow Eye, LLC; billed per 1 mg); J3299 (Xipere from Bausch & Lomb Americas Inc.; billed per 1 mg); J3304 (Zilretta from Pacira Pharmaceuticals, Inc.; extended-release, preservative-free; billed per 1 mg). The ASP crosswalk maps 41 NDCs to it, sold as Kenalog-80, Triamcinolone Acetonide, Kenalog-40 by E.R. Squibb & Sons, L.L.C., Hikma Pharmaceuticals USA Inc., Teva Parenteral Medicines, Inc. 2 Medicare coverage articles list the code across 5 states plus DC and 2 territories, including A57114.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J3301 at $0.787 per 10 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.996 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J3301
QuarterPayment limitPerCoinsurance
October 2026$0.78710 MG20%
July 2026$0.99610 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 41 NDCs from 10 labelers to J3301. Report the NDC in the claim's drug segment and bill the number of J3301 units that equals the quantity administered divided by 10 MG; the last column gives units per full package.

NDCs that crosswalk to J3301
NDCDrug nameLabelerPackage sizeBilling units / package
00003-0293-05Kenalog-80E.R. Squibb & Sons, L.L.C.1 × 14
00003-0293-20Kenalog-80E.R. Squibb & Sons, L.L.C.5 × 120
00003-0293-28Kenalog-80E.R. Squibb & Sons, L.L.C.10 × 140
00003-0315-05Kenalog-80E.R. Squibb & Sons, L.L.C.1 × 18
00003-0315-20Kenalog-80E.R. Squibb & Sons, L.L.C.5 × 140
00003-0494-20Kenalog-80E.R. Squibb & Sons, L.L.C.5 × 15
00143-9387-25Triamcinolone AcetonideHikma Pharmaceuticals USA Inc.1 × 25100
00703-0241-01Triamcinolone AcetonideTeva Parenteral Medicines, Inc.1 × 14
00703-0243-01Triamcinolone AcetonideTeva Parenteral Medicines, Inc.5 × 120
00703-0245-01Triamcinolone AcetonideTeva Parenteral Medicines, Inc.10 × 140
16714-0130-25Triamcinolone AcetonideNorthstar RxLLC1 × 25100
16714-0140-01Triamcinolone AcetonideNorthstar RxLLC5 × 120
16714-0150-01Triamcinolone AcetonideNorthstar RxLLC10 × 140
43598-0676-11Triamcinolone AcetonideDr. Reddy's Laboratories Inc.5 × 15
43598-0694-11Triamcinolone AcetonideDr. Reddy's Laboratories Inc.5 × 120
50090-0256-00Kenalog-40A-S Medication Solutions5 × 120
50090-0295-01Kenalog-40A-S Medication Solutions5 × 15
50090-0819-00Kenalog-40A-S Medication Solutions10 × 140
50090-2360-00Kenalog-40A-S Medication Solutions1 × 14
55150-0384-01Triamcinolone AcetonideEugia US LLC5 × 120
55150-0385-01Triamcinolone AcetonideEugia US LLC10 × 140
67457-0621-02Triamcinolone AcetonideMylan Institutional LLC1 × 14
67457-0621-99Triamcinolone AcetonideMylan Institutional LLC1 × 25100
67457-0622-05Triamcinolone AcetonideMylan Institutional LLC5 × 120
67457-0622-99Triamcinolone AcetonideMylan Institutional LLC5 × 25500
67457-0623-10Triamcinolone AcetonideMylan Institutional LLC10 × 140
67457-0623-99Triamcinolone AcetonideMylan Institutional LLC10 × 251000
70121-1049-02Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 14
70121-1049-05Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 25100
70121-1168-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC5 × 120
70121-1169-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC10 × 140
70121-1651-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 14
70121-1651-05Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 25100
70121-1652-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC5 × 120
70121-1653-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC10 × 140
70121-1654-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC5 × 120
70121-1655-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC10 × 140
70121-1657-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 14
81298-5781-05Triamcinolone AcetonideLong Grove Pharmaceuticals, LLC1 × 25100
81298-5783-03Triamcinolone AcetonideLong Grove Pharmaceuticals, LLC10 × 140
81298-5785-03Triamcinolone AcetonideLong Grove Pharmaceuticals, LLC5 × 120

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J3301. For practitioners the limit is 16 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J3301 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services163 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital163 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J3301 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J3301 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J3301 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J3301 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J3301 in their HCPCS tables, covering 8 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J3301
ArticleTitleContractor(s)StatesRelated LCD
A57114Billing and Coding: Trigger Point InjectionsFirst Coast Service Options, Inc.FL PR VIL33912
A57751Billing and Coding: Trigger Point InjectionsNovitas Solutions, Inc.DC DE MD NJ PAL35010

Diagnoses Medicare contractors cover for J3301

The 2 articles that list J3301 tie their diagnosis groups to other procedure codes, so no covered ICD-10-CM list is attributed to J3301 itself; the diagnosis has to fit the group written for the procedure billed with the drug. See A57114, A57751.

Local coverage policies that list J3301

2 active Local Coverage Determinations list J3301 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J3301 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J3301 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J3301 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J3301

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J3301

What does HCPCS code J3301 describe?

J3301 is defined by CMS as "Injection, triamcinolone acetonide, not otherwise specified, 10 mg". Each billing unit represents 10 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J3301 a CPT code?

No. J3301 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as triamcinolone acetonide; CPT codes are five-character codes maintained by the AMA. On a Part B claim J3301 reports the drug itself in 10 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J3301 in October 2026?

The ASP-based payment limit is $0.787 per 10 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.996. Commercial payers use their own fee schedules.

How many units of J3301 can be billed per day?

The practitioner Medically Unlikely Edit is 16 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J3301?

The October 2026 ASP crosswalk lists 41 NDCs from 10 labelers: Kenalog-80 (E.R. Squibb & Sons, L.L.C.); Triamcinolone Acetonide (Hikma Pharmaceuticals USA Inc.); Triamcinolone Acetonide (Teva Parenteral Medicines, Inc.); Triamcinolone Acetonide (Northstar RxLLC). For example NDC 00003-0293-05 (package size 1) equals 4 billing units of J3301.

Does J3301 have NCCI bundling edits?

No active practitioner PTP pairs list J3301 as a column-1 or column-2 code in the v323r0 release.

J3301 vs J3300: what is the difference?

Both are HCPCS Level II codes whose descriptor names triamcinolone acetonide. What sets J3300 apart: Triesence from Harrow Eye, LLC; billed per 1 mg. J3301 is billed per 10 mg, limit $0.787, MUE 16; J3300 is billed per 1 mg, limit $17.199, MUE 80. Report the code whose descriptor matches the product and setting in the record.

J3301 vs J3299: what is the difference?

Both are HCPCS Level II codes whose descriptor names triamcinolone acetonide. What sets J3299 apart: Xipere from Bausch & Lomb Americas Inc.; billed per 1 mg. J3301 is billed per 10 mg, limit $0.787, MUE 16; J3299 is billed per 1 mg, limit $47.705, MUE 72. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J3301?

2 current Billing and Coding Articles in the Medicare Coverage Database list J3301, covering 5 states plus DC and 2 territories: A57114 (Billing and Coding: Trigger Point Injections); A57751 (Billing and Coding: Trigger Point Injections).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.